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CHALLENGES AND HEALTHCARE QUALITY IMPROVEMENT STRATEGIES 
FOR ASTHMA CARE FOR PRESCHOOL CHILDREN 
GREGORY WILLIAM JEW 
ABSTRACT 
 Asthma is the most common chronic illness in children. Preschool children 
(age 0 to 5) in particular experience a disproportionate disease burden compared 
to all other age groups. Part of the puzzle is the diagnostic challenge presented 
in this age group, and another is the difficulties in the care and management of 
asthma. Compounding the issue are the well-documented racial disparities 
experienced by minorities. This paper reviews the literature documenting the 
difficulties and disparities facing minority preschoolers with respect to providing 
and receiving care for asthma and qualitative improvement strategies targeting 
healthcare. Due to the complexity of the disease, more research on evidence 
based strategies targeting this age group is needed as well as better 
documentation of implementation processes.    
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INTRODUCTION 
 Asthma is the most common chronic illness in children (CDC 2012). 
Preschool children (age 0 to 5) in particular experience a disproportionate 
disease burden compared to all other age groups. Part of the puzzle is the 
diagnostic challenge presented in this age group, and another is the difficulties in 
the care and management of asthma. Compounding the issue are the well-
documented racial disparities experienced by minorities. To address the problem, 
one focus has been on developing qualitative improvement strategies to improve 
the many aspects of care. This paper will shed light on major barriers that the 0 
to 5 age group encounters in receiving care as well as provide examples of a few 
quality improvements strategies aimed at improving the delivery of healthcare. 
 
Background 
 Defining Asthma  
 Asthma is a chronic inflammatory illness affecting the airways. The most 
common symptoms include recurrent wheezing, shortness of breath, chronic 
cough, and chest tightness (Maslan & Mims, 2014).  These symptoms are due to 
lower airway constriction, increased bronchial secretion, mucosal edema, and 
over time can lead to structural changes due to repeated cycles inflammation 
(Fireman, 2003). Symptoms can vary in severity from asymptomatic to life 
threatening episodes triggered by specific environmental allergens (NHLBI, 
2014). As of 2013, over 22 million (7.3%) people in the United States had 
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asthma, over 6 million of these were children under 18 years old (CDC, 2013b). 
Asthma mortality has decreased over the years. In 2013, there were 3630 deaths 
from asthma in the United states (CDC, 2013b). Although asthma is not 
considered a leading cause of death, the burden of asthma is typically 
experienced through medical expenses ($18 billion per year), emergency 
department visits (1.8 million per year), hospitalizations (439,400 per year), and 
days lost from school or work (Centers for Disease Control, 2013). In fact, 
asthma was the third leading cause for hospitalization among children under 18 
years old in the United States and the leading cause of admission to the hospital 
after an emergency department visit (CDC, 2013b; Sullivan et al., 2011; Weiss, 
Wier, Stocks, & Blanchard, 2014). 
 Preschool children (children aged 0 to 5) experience particularly higher 
morbidities due to asthma than another other age group. According to the 
Centers for Disease Control (CDC), prevalence of asthma among children 0 to 4 
is the lowest (6.3%) compared to children 5 to 9 (10%), 10 to 14 (9.4%) and 
adolescents (9.0%) (Centers for Disease Control, 2013), yet have the highest 
rates of emergency department use and hospitalizations  due to asthma (Karaca-
Mandic P, Jena AB, Joyce GF, & Goldman DP, 2012). In the Health of Boston 
2014-2015 report from the Boston Public Health Commission (BPHC), despite 
seeing much improvement over the years, asthma related emergency 
department visit rate for the 3 to 5 age group was about 28 per 1000 people 
while the next highest age group rate, ages 6 to 17, was about 16 per 1000 
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people (See Figure 1) (Boston Public Health Commission, Research and 
Evaluation Office, 2015). These statistics call for further reseach to understand 
and close this disparity. 
 
Figure 1: Emergency Visits by Age and Year in Boston. Figure amended from 
BPHC 2015. 
  
Diagnosis 
 One principal reasons that the 0 to 5 age group experiences such a heavy 
burden of asthma comes from the difficulty in making the diagnosis (Bacharier & 
Guilbert, 2012; Cave & Atkinson, 2014; Ducharme, Tse, & Chauhan, 2014). 
Diagnosing of asthma typically includes a variety of different tools and 
techniques. According to the National Heart, Lung, and Blood Institute (NHLBI), 
the current methods for diagnosing asthma in school-aged children, adolescents, 
and adults include the consideration of medical and family history, findings from a 
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physical exam, results from pulmonary tests, and additional lab tests (Maslan & 
Mims, 2014; National Asthma Education and Prevention Program, 2007). 
 When reviewing medical history, there are certain signs and symptoms 
which are indicative of asthma. These include a history of persistent or recurrent 
wheezing, cough, difficulty breathing, or chest tightness (National Asthma 
Education and Prevention Program, 2007). The likelihood of a diagnosis of 
asthma increases if these symptoms worsen in the event of exercise, viral 
infection, cold weather, or environmental exposures to pollen, pet dander, 
smoke, dust mites, or house pests. Symptoms worsening at night or upon waking 
can also be indicative of asthma. Family history is also a major risk factor for 
asthma (National Asthma Education and Prevention Program, 2007).  
 During physical examination indicators of asthma include hyper-expansion 
of the thorax, sounds of wheezing, prolonged exhalation or other signs of airflow 
obstruction, increased nasal secretion, nasal swelling, or polyps, eczema or other 
allergic skin conditions (National Asthma Education and Prevention Program, 
2007). It is important to note that these signs may be absent even in the 
presence of asthma due to the episodic nature of the disease (National Asthma 
Education and Prevention Program, 2007). 
 The main quantitative tool utilized in the diagnosis of asthma are 
pulmonary function tests (PFTs). The most common of these is spirometry which 
is also considered the current gold standard for the diagnosis of asthma 
(Fuhlbrigge et al., 2001; National Asthma Education and Prevention Program, 
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2007). The specific measurements of interest with respect to asthma include 
"forced expiratory volume in one second (FEV1), forced expiratory volume in 6 
seconds (FEV6), forced vital capacity (FVC), and FEV1/FVC - before and after 
the patient inhales ad short-acting bronchodilator" (Fuhlbrigge et al., 2001; 
National Asthma Education and Prevention Program, 2007). These measures 
allow physicians to objectively assess obstruction severity and bronchodilator 
reversibility as well as distinguish between asthma and chronic obstructive 
pulmonary disease (COPD) which, may share many signs and symptoms with 
asthma, but has a different regimen of treatments, medications, and 
management approach (Celli, 2000; Li & O’Connell, 1996). Unfortunately, these 
measurements require active participation from patients, which with children 
younger than five years old, is not typically possible.  
 More recently, a new tool which measures the fractional exhaled nitric 
oxide (FeNO) has been developed. In brief, a common variant of asthma results 
from eosinophilic airway inflammation (Cohn, Elias, & Chupp, 2004). In these 
cases, increased activation of T-helper cells (Th2) and mast cells increase the 
production of cytokines which in turn increase the production of nitric oxide (NO), 
a known inflammation mediator, in airway epithelium (Maslan & Mims, 2014).This 
NO is exhaled and can be measured to assess air way inflammation (Strunk et 
al., 2003). In this way FeNO can also be utilized as method to measure the 
underlying physiology how patients respond to steroidal treatment which aims to 
decrease inflammation. 
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 For the this reason, the current NHLBI guidelines (2007) consider FeNO 
measurements to be useful in monitoring and assessing asthma (Dougherty et 
al., 2007), however several studies have found FeNO measurements to have 
higher sensitivity in regards to the diagnosis of asthma in certain cases (Deykin, 
Massaro, Drazen, & Israel, 2002; Dweik et al., 2011; Smith et al., 2004). In 2004, 
Smith et al. published a study comparing the efficacy of FeNO measurements to 
conventional methods (spirometry and peak flow meter) in the diagnosis of 
asthma (Smith et al., 2004). This study compared 47 patients of varying ages (8 
to 75) who exhibited respiratory symptoms suggestive of asthma for six weeks 
prior (Smith et al., 2004). Researchers measured FeNO, FEV1 and FEV1/FVC 
before and after steroid (prednisone) treatment, bronchodilator reversibility, peak 
flow, sputum eosinophils, bronchial hyperresponsiveness (BHR). The diagnosis 
of asthma in these patients was based on, "relevant symptom history (present in 
all patients) using American Thoracic Society criteria, and a positive test for BHR 
and/or a positive response to bronchodilator" (Smith et al., 2004).  Smith et al. 
found that spirometry had a sensitivity of 47%, while FeNO had a sensitivity of 
88% (Smith et al., 2004). Furthermore, in 2011, the American  Thoracic Society 
(ATS) published its official clinical practice guidelines which give evidence based 
interpretations of FeNO measurements for diagnosis, as well as other situations 
in which FeNO may be useful (Dweik et al., 2011).   
 Importantly, this method only requires relaxed tidal breathing (Castro-
Rodriguez, 2010). Thus it has the potential to be used in younger children where 
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spirometry is not an option. FeNO measurement is a promising tool that can help 
physicians diagnose and treat asthma early, improving care for those 0 to 5. 
 
Diagnostic Challenge 
 As mentioned above, the inability to use spirometry for preschoolers 
makes an accurate diagnosis a formidable challenge. This in turn leaves 
asthmatic preschoolers undiagnosed, unmonitored, and untreated while on the 
other end of the spectrum, transient wheezers (preschool children who wheeze 
but no longer do after ate six) go over treated (Cave & Atkinson, 2014). The lack 
of available pulmonary function tests and laboratory tests appropriate for this age 
group limits diagnosis to primarily rely upon the recognition of symptoms by the 
parent and physician(Ducharme et al., 2014; National Asthma Education and 
Prevention Program, 2007).  
 The hallmark symptoms of wheezing and cough can be indicative of a 
number of conditions (Bacharier & Guilbert, 2012; Ducharme, Dell, 
Radhakrishnan, Grad, & Zelman, 2015; Ducharme et al., 2014). According to the 
2007 NHLBI guidelines, differential diagnosis for wheezing in infants and children 
include, 
 "allergic rhinitis and sinusitis, foreign body obstruction, vocal cord 
dysfunction, vascular rings or laryngeal webs, 
laryngotracheomalacia, tracheal stenosis, brochiostenosis, 
enlarged lymph nodes, tumors, viral bronchiolitis or obliterative 
bronchiolitis, cystic fibrosis, bronchopulmonary dysplasia, heart 
disease, recurrent cough not due to asthma, and aspiration from 
swallowing mechanism dysfunction or gastroesophageal reflux" 
(Dougherty et al., 2007) (See Table 1).  
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Table 1: Differential Diagnostic Possibilities for Preschoolers with Asthma. Table 
from NHLBI Expert Panel Report 3: Guidelines for the Diagnosis and Management 
of Asthma 2007. 
 
 
 Out of these, the most common cause of wheezing besides asthma is 
bronchiolitis (Ducharme et al., 2014). Briefly bronchiolitis is the inflammation of 
the bronchioles usually due to respiratory syncytial virus (RSV)(Koehoorn et al., 
2008; Papadopoulos et al., 2002). While the treatments RSV bronchiolitis 
responds to are very different from asthma (ie bronchiodialators, inhaled 
corticosterioids)(Ducharme et al., 2014), severe cases of bronchiolitis resulting 
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from RSV have been shown to be a powerful risk factor for asthma and allergic 
sensitization in early age (Sigurs, Bjarnason, Sigurbergsson, & Kjellman, 2000). 
 Further complicating the diagnosis of asthma in preschoolers is the fact 
that nearly half of preschool children wheeze yet 60% no longer do so after age 
six (transient wheezers) and fewer still go on to develop asthma (Martinez et al., 
1995). One attempt to identifying preschool wheezers who are at risk for 
developing asthma has been to distinguish between wheeze phenotypes 
(Taussig et al., 2003). The Tucson Children's Respiratory Study followed 1246 
newborns and their families to explore the relationships between potential risk 
factors, acute lower respiratory tract illnesses, and chronic lung disorders into 
childhood and early adulthood (Taussig et al., 2003). With regards to wheezing 
researchers identified three wheezing phenotypes. 1) Early transient wheezers 
(those who began wheezing before age three, but no longer did at the age of six) 
made up 20% of all children, 2) persistent wheezers (those who started wheezing 
before age tree and continued to do so at age 6) made up 14% of all children, 
and 3) late-onset wheezers (children who started wheezing between ages three 
and six) made up 15% of all children (Taussig et al., 2003). Persistent wheezers 
and late-onset wheezers, especially those with additional risk factors were the 
most likely to continue on to experience asthma-like symptoms (Taussig et al., 
2003).  
 Furthermore some physicians prefer to wait until quantitative pulmonary 
function tests (spirometry) to measure bronchodilator reversibility and bronchial 
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hyperresponsiveness are available to make the formal diagnosis of asthma (Celli, 
2000; Ducharme et al., 2014; Fuhlbrigge et al., 2001; Li & O’Connell, 1996; 
National Asthma Education and Prevention Program, 2007). As a result the 
condition of many young children who have had few instances of wheezing may 
receive ambiguous labels "denoting a suggestive pathophysiology (eg, 
‘bronchospasm’ or ‘reactive airway disease’), symptoms (eg, ‘wheeze’ or ‘chronic 
cough’), vague  diagnoses (‘wheezy bronchitis’ or ‘happy wheezer’) or, possibly, 
inappropriate diagnoses (eg, repeated ‘bronchiolitis’ or ‘recurrent bronchitis or 
pneumonia’)" (Ducharme et al., 2015).  
 To aid in predicting preschoolers' risk of developing asthma, researchers 
developed the Asthma Predictive Index (API)(Castro-Rodriguez, 2010; Castro-
Rodríguez, Holberg, Wright, & Martinez, 2000). The API, created in 2000, is 
comprised of major and minor criteria which are examined within the first three 
years of life (See Table 2).  
"A positive API score requires recurrent episodes of wheezing 
during the first 3 years of life and 1 of 2 major criteria (physician-
diagnosed eczema or parental asthma) or 2 of 3 minor criteria 
(physician-diagnosis allergic rhinitis, wheezing without colds, or 
peripheral eosinophilia ≥4%). A loose index (<3 episodes/y and 1 of 
the major or 2 of the minor criteria) and a stringent index (≥3 
episodes/y and 1 of the major or 2 of the minor criteria) were 
created. A positive stringent API score by the age of 3 years was 
associated with a 77% chance of active asthma from ages 6 to 13 
years; children with a negative API score at the age of 3 years had 
less than a 3% chance of having active asthma during their school 
years" (Castro-Rodriguez, 2010).  
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 When tested for its predictive values, the API had a sensitivity of 22%, 
specificity of 97%, positive predictive value of 77%, and negative predictive value 
of 90%. Due to these values, the API's true strengths lie in its ability to rule out 
asthma as a likely diagnosis in preschool children. 
 Recently, the API has been modified to include allergic sensitization to at 
least one areoallergen as a major criteria, and allergic sensitization to milk, egg, 
or peanut has replaced allergic rhinitis as a minor criteria(Guilbert, 2010). 
Consideration of modified asthma predictive index (mAPI) scores has been 
included in the 2007 NAEPP guidelines as a step to initiating control therapy for 
children 0 to 4 (National Asthma Education and Prevention Program, 2007).  
  Other indices that rely upon different measures have also been developed 
such as the Isle of Wight from the United Kingdom (Kurukulaaratchy, Matthews, 
Holgate, & Arshad, 2003), and (Prevention and Incidence of Asthma and Mite 
Allergy (PIAMA) (Caudri et al., 2009), but so far have not been included in 
guidelines used within the Unites States. 
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Table 2: Asthma Predicive Index (API) and Modified Asthma Predictive Index 
(mAPI). Table from Bacharier and Guilbert 2012. 
 
Risk Factors: 
 Despite asthma's high prevalence and heavy burden on patients and the 
healthcare system, gaps in our knowledge of causes, pathways, and therapies 
remain. The cause of asthma remains unknown and no cure has been 
developed. As a result of these gaps, symptom control continues to be the 
primary means of reducing mortality and asthma burden (National Heart Lung 
and Blood Institue, 2012). While this strategy has seen success in reducing 
asthma mortality rates, it becomes clear that a better understanding of the 
causes and risk factors is necessary to develop and apply novel upstream 
preventative approaches. These primary preventative interventions will help to 
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reduce prevalence of asthma, reducing its burden on patents and healthcare 
system (Collaborators, 2015). Additionally, analyzing risk factors may not only 
give clues to understanding the underlying causes of asthma, but also may also 
help to improve the management of those currently with the illness. 
 In a recent review published in 2015, Beasley et al. presents a 
comprehensive list of known risk factors and their association with asthma 
(Beasley, Semprini, & Mitchell, 2015) (See Table 3). In understanding risk factors 
it is important to distinguish between risk factors that are associated with the 
development of asthma and risk factors that are associated with the exacerbation 
of asthma symptoms once it has already be established. Beasley et al. as well as 
the guidelines for the National Heart, Lung, and Blood Institute report that the 
interplay between genetic factors and environmental exposures during immune 
system development are key elements in the onset and development of asthma 
(Beasley et al., 2015; Dougherty et al., 2007).  
 From the genetic standpoint, the link between genes and family history is 
both unclear and very complicated (Beasley et al., 2015; Maslan & Mims, 2014; 
National Asthma Education and Prevention Program, 2007). Multiple loci across 
multiple chromosomes have been found to be associated with development of 
asthma with varying degrees of risk, yet they lack a straight forward Mendelian 
pattern of inheritance, marking them as areas for further investigation (Beasley et 
al., 2015; Maslan & Mims, 2014). 
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Table 3: Risk Factors Association with Asthma. Taken from Beasley, 2015.  
 
 Preterm birth is also a well documented risk factor. In a meta-analysis of 
147,252 European children by Sonnenschein-van der Voort et al. 
(Sonnenschein-van der Voort et al., 2014), younger gestational age at birth was 
highly associated with the development of asthma at school age. Researchers 
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reported that children born preterm with high infant weight gain were more likely 
to have childhood asthma (OR = 4.47, 95% CI, 2.56 to 7.76) and wheeze (OR= 
1.34 95% CI, 1.25 to 1.43) than children born at full term (Sonnenschein-van der 
Voort et al., 2014). Earlier births increased the likelihood of both wheezing in 
preschoolers and childhood asthma (Sonnenschein-van der Voort et al., 2014). 
(See Figure 2).  
 See Table 1 for other risk factors. 
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Figure 2: (A) Gestational Age at Birth and the Risk of Preschool Wheezing. (B) 
Gestation Age at Birth and the Risk of Childhood Asthma. Figure from 
Sonnenschein-van der Voort et al. 2014. 
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Controlling Asthma 
 Once the diagnosis of asthma has been established, since it cannot 
currently be cured, the goal of treatment is to control symptoms and prevent 
exacerbations. The NAEPP guidelines state that the four components to asthma 
management are: 1) assessment and monitoring, 2) education for partnership in 
care, 3) control of environmental factors and co-morbidities, and 4) medication 
(National Asthma Education and Prevention Program, 2007). Although each 
component is equally important in effective care, guideline recommendations for 
partnering and educating and patients (or caregivers) and controlling for 
environmental factors are the same among all age groups. Thus only the 
assessment and medication component will be discussed here. 
 
Asthma Severity and Control Assessments 
 Currently, the NAEPP guidelines have severity of symptoms, nighttime 
awakenings, interference with normal activity, and short-acting beta2 - agonist 
(SABA) use for episodic symptom relief as components in determining severity 
and control (National Asthma Education and Prevention Program, 2007). 
Physicians also rely upon these components when deciding how to adjust 
therapy. 
 Example of generic questionnaire questions are, "How many days in the 
past week have you had chest tightness, cough, shortness of breath, or 
wheezing (whistling in your chest)? Have you had any unscheduled visits to a 
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doctor, including to the emergency department, since your last visit? What is the 
average number of puffs per day of quick-relief medication (short acting beta2-
agonist)?" (National Asthma Education and Prevention Program, 2007).  
 To carry out assessments, questionnaires are commonly used to assess 
these components. Questionnaires include the Asthma Therapy Assessment 
Questionnaire (ATAQ) (Vollmer, 2004), the Asthma Control Questionnaire (ACQ) 
(Juniper, O′byrne, Guyatt, Ferrie, & King, 1999), and the Asthma Control Test 
(ACT) (Nathan et al., 2004). Each of these tools have been evaluated and 
validated for their efficacy in identifying patients at risk for adverse asthma 
outcomes in adults, but unfortunately these tools have not yet been validated in 
assessing asthma severity those under the age of five (Juniper et al., 1999; 
Nathan et al., 2004; Skinner et al., 2004; Vollmer, 2004). 
 The goal of assessing severity is to apply the correct treatment regimen. 
Depending on the severity, patients' asthma without medication is categorized 
into 1) intermittent, 2) mild, 3) moderate, or 4) severe. For children ages 0 to 4, 
intermittent asthma severity means two or less symptoms per week, zero night 
time awakenings, using short-acting beta2-agonists (SABAs), no interference 
with normal activities, one or less exacerbations requiring oral steroids. A child 
with between two and six symptom days per week, one or two nighttime 
awakenings per month, between two and six SABA usages per week, minor 
limitations in regular activity, and more than two episodes in six months requiring 
the use of oral steroids, OR four or more episodes of wheezing in the last year 
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that last longer than one day and has risk factors for persistent asthma has mild 
asthma. Moderate and severe asthma experience more frequent symptoms, 
more nighttime awakenings, more frequent SABA use, and  increasing limitations 
to normal activities (National Asthma Education and Prevention Program, 2007) 
(See Table 4). 
 The NHBLI Guidelines have developed a stepwise treatment plan to help 
providers apply the appropriate therapy (National Asthma Education and 
Prevention Program, 2007). Once Severity has been established, the child can 
be started on the recommended corresponding step. (See Figure 5) The 
guidelines recommend children with intermittent asthma on step one, children 
with mild asthma on step 2, and moderate and severe on step 3 (National 
Asthma Education and Prevention Program, 2007). During assessments for 
control, if the child presents with similar symptoms to a mild severity or worse, 
the child's asthma is considered not well controlled and the provider is 
recommend to step-up therapy to the next step. If the child presents with 
intermittent severity, the child's asthma is considered well controlled and the 
provider is recommended to maintain the current step or consider step a step-
down if control is maintained for 3 months (National Asthma Education and 
Prevention Program, 2007). It is important to note that if no improvement is found 
after four to six weeks of daily inhaled cortiosteroid (ICS) use, it is recommended 
to consider alternate diagnoses. 
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Corticosteroid Medications 
 One of the key pillars in managing asthma and controlling its symptoms is 
medication. Medications are typically divided into long-term controller medication, 
and short-term rescue medication. Controller medications are aimed at 
controlling airway inflammation. Typically controller medications include, 
"corticoid steroids (inhaled [ICSs] or oral),  cromolyn sodium and nedocromil, 
immunomodulators, leukotriene modifiers, long-acting beta2-agonists (LABAs), 
and methylxanthines" (National Asthma Education and Prevention Program, 
2007). 
 The most common of these are ICSs due to its relatively high efficacy 
(Castro-Rodriguez, Custovic, & Ducharme, 2016). A randomized control study by 
Guilbert et al. examined the effects of early ICSs use in preschool children at 
high risk for asthma (Guilbert et al., 2006). In this study, researchers randomized 
two groups of children. One group was given an ICS (fluticasone propionate 
[Flovent]) to take two 44ug puffs twice daily, the other group was given a similar 
placebo. Each group was also given rescue medication of albuterol in either puff 
inhaler or nebulizer and four day oral corticosteroid (prednisone) treatment to be 
taken during episodes of exacerbation (Guilbert et al., 2006). Two groups were 
monitored over the next two years, then treatment was discontinued from the 
experimental group and both were observed for an additional year. The main 
outcome was symptom free days. The results were that the treatment group 
 23 
 
experienced more symptom free days (93.2%) than the placebo group (88.4%) 
during the first two treatment years (Guilbert et al., 2006). Importantly the 
treatment group experience no significant change in the proportion of episode 
free days during the treatment period (97% to 96%), while the control group 
experienced a decline (96% to 89%). During the observation year, the treatment 
group (86.8%) did not show any significant improvement over the placebo group 
(85.9%). In fact, both groups experienced a decreasing proportion of symptom 
free days (See Figure 6) (Guilbert et al., 2006). These findings support the theory 
that ICSs are effective in reducing asthma symptoms and thus the burden of 
disease in those with high risk for asthma. However, during the observational 
period, once ICS treatment was stopped, both groups had similar outcomes. This 
in particular shows that early ICS treatments only have symptomatic benefit but 
do not have a preventative effect on the development of asthma in high-risk 
children (Guilbert et al., 2006). 
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Figure 4: Proportion of Asthma Episode (Symptom) Free Days, ICS (Flucticasone) 
vs Control. During the two year treatment period, children in the treatment group 
(blue) experienced a significant higher proportion (93.2%, 95% CI= 91.1% to 94.9%)  
of asthma episode days when compared to the control group (red) (88.4%, 95% CI 
= 84.9 to 91.2%, P=0.006). More notably, the during the treatment period the 
proportion of episode free days remained unchanged for the intervention group  
over the two years (97% to 96%), while the control group experienced a decline 
(96% to 89%). During the observation period, the proportion of episode free days 
for the intervention group declined to match the control group. (Figure from 
Guilbert 2006) 
 
 Long term use of corticosteroids are well documented to have a wide 
range of side effects that vary from cataracts to hypertension. However, ICSs are 
typically recommended in doses low enough to avoid them or taken injunction 
with non-steroidal anti-inflammatory drugs such as LABAs or leukotriene 
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moderators, especially for mild to moderate asthma (Lipworth BJ, 1999; National 
Asthma Education and Prevention Program, 2007). It is important to note that 
increased dose, prolonged use (longer than one year), and oral systemic 
corticosteroids increase the risk of side effects such as cataracts and reduced 
bone density (Lipworth BJ, 1999; National Asthma Education and Prevention 
Program, 2007).  
 One side effect of ICSs that is of particular concern is decreased linear 
growth rates. Thus in the previously mentioned study by Guilbert et al. (Guilbert 
et al., 2006), researchers also examined the effect of early ICS on growth rates. 
They found children in the placebo group grew 1.1 cm more than those in the 
treatment group at the end of two year treatment phase, and 0.7 cm more at the 
end of the one year observation phase (Guilbert et al., 2006). A recent review of 
the various asthma treatments concluded that there is limited evidence that ICS 
use may be associated with growth suppression in preschoolers. The evidence 
supports that, "the growth suppression appears neither progressive nor 
regressive, and it is not cumulative beyond the first year of therapy" (Castro-
Rodriguez et al., 2016). Also, some ICS are known to have more growth 
suppression effects than others. Thus, providers should prescribe the least 
growth suppressive medication at the lowest effective dose. Providers should 
also monitor growth of the children on ICS therapy since susceptibility can vary 
widely from person to person (Castro-Rodriguez et al., 2016). 
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 Overall, despite the fact that our current guideline medications (inhaled 
corticosteriods) are neither preventative nor cures, our current body of evidence 
implies that early administration of such therapy can greatly diminish adverse 
outcomes for preschool children with asthma with relatively few side effects. This 
fact highlights the importance of improving awareness to reduce the under 
diagnosis of asthma in preschool children as well as adherence to prescribed 
therapies. 
  
Racial Disparities and Asthma 
 Race also plays a key role in the outcomes of asthma. One of the issues 
surrounding asthma disparities is how it disproportionately burdens urban vs. 
rural, black and Hispanic vs. white, low income vs. high income, and youth vs. 
adults (Akinbami, Moorman, Simon, & Schoendorf, 2014) (See Figure 6). In the 
2013 National Health Interview Survey (NHIS), asthma was found to be more 
prevalent in black and Puerto Rican children under 18 years old when compared 
to white children (13.4% and 20.7% compared to 7.5% respectively) (CDC, 
2013a). With respect to income, asthma prevalence rates are inversely 
proportional to income. Of those living below 100% of the federal poverty level, 
10.9% had asthma compared to 7.0% for those living between 100% and 250% 
of the poverty level and even lower prevalence for those with higher incomes 
(CDC, 2013a). To compound this disparity, minorities compared to whites not 
only experience higher prevalence but also more severe asthma and worse 
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health outcomes due to asthma. Blacks tend to fare far worse in a number of 
health indicators for asthma including of emergency department visits (254.4 
compared to 77.9 per 10,000), hospitalizations (33.3 compared to 10.1 per 
10,000), and deaths (8.6 compared to1.2 per 10,000) when compared to whites 
(Akinbami et al., 2014).  
 
Figure 5: Emergency Department Visits by Age and Race/Ethnicity, Boston 
2012. Amended from Health of Boston Report 2014-2105 
 
 Disparities in quality of care in young minority children with asthma is also 
an area that needs attention. A study by Finkelstein et al.(Finkelstein et al., 
1995), examined the differences in quality of care by patient race and source of 
treatment in children age 1 to 6. Using discharge records from a tertiary hospital, 
researchers compared use of beta-agonists and anti-inflammatory medication 
(ICS or cromolyn) before admission as a proxy for quality of outpatient care, 
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intensity of beta-agonist therapy within the emergency department and length of 
stay as a proxy for quality of in-hospital care, and prescriptions for nebulizer at 
home as a proxy for the quality of post-hospital care. Payment methods were 
divided into three categories, public (medicaid), private, and "self pay" 
(uninsured.) The results indicated significant differences in quality of care based 
on race after adjusting for age, gender, source of payment, and prior 
hospitalizations. Compared to whites, Hispanics were found to be much less 
likely have received beta-agonists (OR = 6.3) or anti-inflammatory medications 
(OR = 4.9) prior to admission, and much less likely to receive a nebulizer upon 
discharge (OR 14.6). Blacks, on the other hand, were just as likely to receive 
beta-agonists but less likely to receive anti-inflammatory medication (OR = 3.9) 
before admission, and also less likely to receive nebulizers (OR = 4.5) upon 
discharge when compared to whites. It is important to not, however, that after 
adjusting for primary care practice type as well (e.g. hospital clinics, private 
practices, community health centers, private practice, or subspecialty practice), 
only differences in receiving nebulizers upon discharge were significantly 
different. No differences in in-hospital care were found (Finkelstein et al., 1995). 
Findings from this study show that post hospitalization care varies by race. 
Furthermore the study suggests that care for asthma in different primary care 
settings varies, and access to different settings based on race may play a role in 
the disparities in care received.  
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 In a retrospective study by Ortega et al.(Ortega et al., 2002), researchers 
examined a number of factors including the impact of source of care on asthma 
medication use by race and ethnicity. Researchers reviewed parent-reported 
questionnaires from The Childhood Asthma Severity Study for children ages 12 
and under with asthma in Connecticut and Massachusetts. Several analyses 
were done to adjust for "child's age, gender, insurance status, asthma severity, 
number of scheduled visits for asthma to the regular provider, number of urgent 
visits for asthma to the regular provider, family income, and maternal education, 
practice type", and site of care (Ortega et al., 2002). Results from this study 
showed a base level of inequalities. When compared to whites, blacks and 
Hispanics were much more likely to have lower income (7% compared to 52% 
and 62%), lower maternal education (78% having more than high school 
education compared to 43% and 25%), and less likely to be seen in private 
practices (92% compared to 52% and 40%). When comparing asthma 
medication use by type of practice, patients whose primary site of care was 
private practices were twice as likely to use inhaled steroids over 30 times in the 
last year (15%) when compared to those using ambulatory care centers (7%) or 
hospital based clinics (7%)(Ortega et al., 2002), agreeing with the results from 
the Finkelstein et al. study. Most importantly when the scope of analysis was 
narrowed to differences within just private practices, asthmatic black and 
Hispanic children were less likely to have used inhaled steroids in the past year 
(OR = 0.5 and 0.3 respectively) (Ortega et al., 2002). Overall researchers 
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concluded that minority children are less likely to receive the optimal asthma care 
compared to whites even after adjusting for other socioeconomic, healthcare 
statuses, and behaviors.  
 In addition to site and quality of care, it has been well documented that 
use of specialty care (e.g. allergist, pulmonologist) improves asthma outcomes in 
children (Diette et al., 2001; Schatz et al., 2005). To explore how access to 
specialist care, poverty, and quality of care affect the morbidity of asthma in 
urban minority children, Flores et al. performed at cross sectional study (Flores et 
al., 2009). In this study, participants were 220 black and hispanic children ages 2 
to 18 who were admitted into the emergency department or inpatient ward for 
asthma. Researchers administered questionnaires to caregivers regarding 
sociodemographic and healthcare characteristics, and health status. "Primary 
study outcomes included (1) asthma exacerbations; (2) missed school days; (3) 
parental missed workdays; (4) asthma ED visits; (5) asthma hospitalizations; (6) 
asthma doctor visits; (7) used the ED as the usual asthma care source; (8) 
having an asthma specialist; and (9) having a written asthma care plan" (Flores 
et al., 2009). Findings from this study show significant advantages associated 
with having an asthma action plan, and having an asthma specialist, and 
significant disadvantages associated with being in poverty. Specifically, children 
with asthma action plans had on average 17 asthma exacerbations per year 
compared to an average of 27 exacerbations per year for children without action 
plans. Furthermore, children with specialists had on average half as many 
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asthma exacerbations (seven)  as those without a specialist .(Flores et al., 2009). 
Meanwhile, "poor children were much less likely to have an asthma specialist 
than non-poor children (13% vs. 26%)" (Flores et al., 2009). These findings 
suggest the need for improved access to specialist care among minorities and 
impoverished and suggest that a relatively simple solution (providing more 
asthma action plans) may be readily available to help reduce morbidity. 
 It is important to note that while many studies address disparities within 
race, minority status, and socioeconomic status, only a small proportion include 
the age range 0 to 5 and none were found that had that age range as a focus 
despite a remarkably higher burden in that group as mentioned in previous 
sections. Furthermore, while many studies document the disparities, few 
examine underlying causes as to why they exist. Some proposed theories are 
lack of access to care, low health literacy, environmental injustices, low 
education attainment, exposure to violence or trauma, increased caregiver 
stress, and genetic factors (Beck et al., 2014; Williams, Sternthal, & Wright, 
2009). Many of these are inevitably interrelated and tightly intertwined.  
 
QUALITY IMPROVEMENT  
 To tackle some of the issues and disparities in care facing minority 
preschoolers with asthma, a multitude of interventions have been proposed and 
evaluated (Bravata et al., 2007; Bravata DM, Gienger AL, Holty JC, & et al, 2009; 
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Okelo et al., 2013). The categories that Agency for Healthcare Research and 
Quality (AHRQ)  have used to organize quality improvement strategies are: 
 "1) Provide reminders [or decision support]- Information tied to a 
specific clinical encounter, provided verbally, in writing, or by 
computer, that is intended to prompt the clinician to recall 
information, or to consider performing a specific process of care. 
 
2)Facilitated relay of clinical data to providers - Clinical information 
collected directly from patients is relayed to the provider in 
situations where the data are not generally collected during a 
patient visit, or when collected using a means other than the 
existing local medical record system. 
 
3) Audit and Feedback - Any summary of a health care provider's 
clinical performance or an institution's clinical performance that is 
reported, either publicly or confidentially, to or about the clinician or 
institution. 
 
4) Provider Education- Any intervention that includes one of the 
following sub-strategies: educational workshops, meetings, and 
lectures; educational outreach visits; or the distribution of 
educational materials  
 
5) Patient Education - Patient education—for individuals or 
members of a patient group or community, presented either in 
person or via the distribution of printed or audio-visual educational 
materials. 
 
6) Promotion of Self-monitoring or Self-management - The 
distribution of materials or access to resources that enhances 
patients' ability to manage their condition, the communication of 
clinical test data back to the patient, or follow up phone calls from 
the provider to the patient with recommended adjustments to care. 
 
7) Patient reminders- Any effort directed toward patients that 
encourages them to keep appointments or adhere to other aspects 
of self-care" (Shojania, McDonald, Wachter, & Owens, 2004). 
 
 Although there are many aspects of asthma care and interventions are 
typically designed to be multifaceted to encompass the many aspects, they can 
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be categorized by the general domains they target: provider/healthcare, family, 
home environment, community/policy. Below are a few select interventions 
aimed at the healthcare side of asthma. 
 A well documented provider side problem is a lack of physician adherence 
to established guidelines for asthma care (Cabana et al., 2000; Cabana MD, 
Rand CS, Becher OJ, & Rubin HR, 2001; Doerschug, Peterson, Dayton, & Kline, 
1999; Okelo et al., 2013; Picken, Greenfield, Teres, Hirway, & Landis, 1998). 
There is a wide range of documented barriers which vary from lack familiarity or 
agreement with the guidelines to lack of effective communication with caregivers 
(Cabana et al., 2000).  
Decision Support 
 One example of an intervention targeting these barriers utilized the 
"decision support" and "facilitated relay of clinical data to providers" strategies. It 
was evaluated in a randomized control trial by Kattan et al. (Kattan et al., 2006). 
In this study participants were children with mild to severe asthma recruited from 
low income census tracts (at least 20% of households with incomes below the 
federal poverty line) in large urban cities within the United States. For all 
participants, the child's caretaker was interviewed over the phone every two 
months to collected data such as asthma symptoms,  use of medical services 
(emergency department visits, physician visits, etc.), and use of asthma 
medications. Data from these calls was used to create a feedback letter 
containing a brief summary of the data collected from the interview, a one-
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sentence recommendation based on severity classification according to the 
National Asthma Education Prevention Program (NAEPP) guidelines, and 
information to encourage the physician to contact the patient (Kattan et al., 
2006). Recommendations were either to step up, down, or make no changes to 
the child's treatments. These letters were mailed to the child's primary care 
physician in the intervention group, no letters were sent to physicians in the 
control group. Physicians were interviewed at the conclusion of the study to 
determine how letters affected asthma care and barriers to following 
recommendations (Kattan et al., 2006).  
 Children in the intervention group experienced fewer emergency 
department visits when compared to children in the control group (0.87 compared 
to 1.14 visits per year, P=0.013) (Kattan et al., 2006). Other outcome measures 
such as symptom days, hospitalizations, and missed school days showed no 
statistically significant differences between groups. Out of the step-up letters, 
17.1%  were followed by a scheduled medical visit in the following 2 months in 
the intervention group compared to 12.3% in the control group (P= 0.005). Of 
these visits, 46% resulted in a medication step-up in the intervention group 
compared to 35.6% in the control group (Kattan et al., 2006). In a subgroup 
analysis of these results to determine the effects of earlier step-up medication, 
the interventions group experienced "fewer asthma symptom days per two weeks 
(3.92 vs 5.03 P=0.02), fewer school absences (0.77 vs 1.24 P=0.004), and fewer 
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unscheduled clinic visits during the year (0.47 vs 0.73 P=0.56)" (Kattan et al., 
2006) (See table 5).  
 
Table 5: Comparison Between Intervention Group and Control Group of a Decision 
Support Intervention. SE = standard error. Table from Katten et al. 2006. 
 
 
 In a simple cost-effective analysis on the intervention, researchers 
estimated the cost to be about $69.20 per child for the year based on typical 
clerical wage rates and number of calls made that year. This amount was added 
to the cost of health service utilization over the year in the intervention group and 
compared to the costs of health service utilization in the control group. 
Researchers reported that there was an estimated $337 saved per child saved 
by the intervention (Kattan et al., 2006). 
 Unfortunately researchers did not measures the providers' perspective on 
the intervention. However, they did monitor physician behavior upon receiving a 
step-up letter. Physicians reported sometimes or always read the feedback letter 
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99% of the time, and 82% of physicians sometimes or always reviewed the 
patient's charts chart after receiving a step-up letter (Kattan et al., 2006). 
Furthermore, 73% of physicians attempted to contact the patient and 28% of 
physicians reported that their patients would not make follow up appointments. 
Only 9.4% of physicians disagreed with the letters (Kattan et al., 2006). 
Provider Asthma Education: 
 An example of and intervention that uses the provider education strategy 
can be found in a randomized control study by Clark et al. (Clark et al., 2000). In 
this intervention, investigators introduced an interactive seminar to practicing 
pediatric physicians to examine any resulting changes in behaviors with regards 
to their administering clinical treatment of asthma, teaching and communicating 
with patients, and patient outcomes (Clark et al., 1998).  The intervention was 
based on the theory of self-regulation, and aimed to encourage physicians to 
develop partnerships with their patients. the two main components were 
promoting NAEPP guideline adherence and improving patient teaching and 
communication (Clark et al., 1998). These aims were carried out through the use 
of lectures, video examples, case studies, providing patient communication self-
assessment protocols, and patient teaching messages and tools. Patient 
caregivers and their physicians were surveyed before the physician was 
randomly placed in to either the control or program group. Physicians completed 
follow-up surveys after 5 months and caregivers were interviewed after their first 
visits (Clark et al., 1998). Physicians and caregivers in the intervention group self 
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reported improvement over the control group in a number of fields. The study 
found that physicians in the program group were more likely to prescribe anti-
inflammatory therapies, provide education, and be reassuring, fear-reducing, and 
informative. Moreover, parents in the intervention group on average felt more 
prepared to manage asthma at home. They rated their physicians more favorably 
despite physicians reporting spending less time with patients(Clark et al., 1998) 
(See Table 6). It is also important to note that ED visits overall did not decrease 
between groups but for low income children (family income <$20,000 per year), 
program group had .57 visits per year compared to 1.57 in the control group 
(Clark et al., 1998).  
 Provider education may seem like one of the more obvious, simple, and 
inexpensive methods to improve provider adherence to guideline care. However, 
many have implemented and evaluated this strategy with mixed results (Bravata 
et al., 2009; Brown et al., 2004; Okelo et al., 2013; Weingarten et al., 2002). One 
systematic review of interventions that used provider education strategies to 
improve chronic disease care by Weingarten et al.(Weingarten et al., 2002) found 
that 12 out of 24 studies (50%) improved adherence measures. A separate 
systematic review of quality improvement strategies for asthma care by Bravata 
et al.(Bravata et al., 2009) found that out of seven studies, "all but 1 study found 
statistically significant improvements in use of medications (most often increases 
in the use of inhaled controller medications).  
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Table 6: Patient Survey Response about Clinician (top) and Patient Healthcare 
Utilization (bottom). T=Treatment Group, C= Control Group. NS= non-significant. Survey 
responses used Likert-type scores where 1=  strongly disagree, 6= strongly agree, 
unless otherwise noted. Table from Clark et al. 1998.   
 
Several found improvements in asthma symptoms and reductions in emergency 
department use" (Bravata DM et al., 2009). However they cite that,  
"Given the small number and heterogeneity of these studies, we 
cannot evaluate the specific provider education intervention 
characteristics most likely associated with improvements in clinical 
outcomes" (Bravata DM et al., 2009).  
The first point of having a small sample size may tie in with the second point 
regarding the heterogeneity of studies, as diversity in study design and chosen 
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measured outcomes may render some incomparable. This is a common issue 
encountered when evaluating programs and meta-analyses. The heterogeneity is 
in reference to both measured outcomes which can make interventions difficult to 
compare, but also is in regards to the programs themselves. For example 
programs that use the strategy of "provider education" vary on a multitude of 
factors from dose, material (eg care guidelines, communication skills, or cultural 
competency), and quality of teaching (eg one-on-one lectures or group 
interactive sessions). 
Care Coordination 
 Care coordination is also key quality improvement strategy. The AHRQ 
offers a definition for care coordination: 
 
"Care coordination is the deliberate organization of patient care 
activities between two or more participants (including the patient) 
involved in a patient's care to facilitate the appropriate delivery of 
health care services. Organizing care involves the marshalling of 
personnel and other resources needed to carry out all required 
patient care activities, and is often managed by the exchange of 
information among participants responsible for different aspects of 
care" (McDonald et al., 2007).  
 
 40 
 
 Although care coordination is not exclusively a provider side intervention, 
it is often incorporated into the healthcare setting and carried out between 
healthcare providers or, if a case manager is involved, by a healthcare worker 
(eg nurse, nurse practitioner). Reasons for this vary from sustainability, to ease 
of implementation and financial incentives (Stoll et al., 2015; Taylor et al., 2013; 
Woods et al., 2012).  
 This is coordination of care is particularly important to asthma when 
considering the variety of services commonly used by asthmatics. Services 
include primary care physicians, specialists such as pulmonologists and 
allergenists, urgent care clinics and emergency department, and intensive care 
units when hospitalized. Just within the healthcare system, the lack of 
communication between services and between patients can lead to missed follow 
ups, or confusion over medications (Butz et al., 2012; Fredrickson, Molgaard, 
Dismuke, Schukman, & Walling, 2004; Leickly et al., 1998; Peláez et al., 2015; 
Swartz, Banasiak, & Meadows-Oliver, 2005). Coordination is not only important 
within the clinic setting, there are public services and resources that require 
referral to receive. Examples from Boston are the Boston Asthma Home Visit 
Collaborative, and Breathe Easy at Home.  
 The Boston Asthma Home Visit Collaborative is a Boston Public Health 
Commission program that trains Community Health Workers to conduct home 
visits. During these visits, the community health workers provide asthma 
education, environmental assessments, and additional referrals to other 
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programs including smoking cessation programs, Healthy Baby Health Child, 
Breathe Easy at Home, etc (Boston Public Health Commission, 2016).   
 Breathe Easy at Home is a city run program and part of Inspectional 
Services designed to help tenants resolve substandard housing conditions with 
special attention to issues that exacerbate asthma such as mold, cockroaches, 
and mice (City of Boston, 2014).  
 These programs directly align with the NAEPP guidelines which highlight 
patient education and controlling environmental factors and pillars as two of the 
four components of care (Dougherty et al., 2007). Recruitment of these programs 
require referral from a provider which proved to be a challenge along with 
connecting with patients to schedule visits (NHLBI, 2013). 
 One strategy to address problems with coordination is to involve case 
managers, community health workers, or other support teams who can 
coordinate the various health care and social services as well as act as patient 
advocates to ensure patients receive the appropriate care.  
 The AHRQ outlines the components of care coordination to be:  
"1) Identifying and assessing the patient, 2) Develop care plan, 3) 
Identify participants in care and specify roles, 4) Communicate to 
patients and all other participants, 5) Execute care plan, 6) Monitor 
and adjust care, and 7) Evaluate health outcomes" (McDonald et 
al., 2007). 
 
 The example the AHRQ gives as an program that contains many 
components of care coordination is the Geriatric Resource Assessment and Care 
for Elders (Counsell, Callahan, Buttar, Clark, & Frank, 2006; McDonald et al., 
 42 
 
2007) (See table 7). Although geriatric care and asthma care may seem widely 
different and the target age groups are on opposite sides of the spectrum, many 
of the same components and themes used in the GRACE intervention have been 
used to improve care for asthma. These include targeting low-income minority 
patients, home visits for assessment and education (City of Boston, 2014; 
NHLBI, 2013; Shani et al., 2015), coordinating specialty care (pulmonologist, 
allergists) (Diette et al., 2001; Schatz et al., 2005), improving self-management of 
chronic conditions, reducing emergency and acute care use, improving follow-up 
rates with PCPs after acute care use (Butz et al., 2012), promoting preventative 
care (Fredrickson et al., 2004), and integration with community services (City of 
Boston, 2014; Findley et al., 2011; NHLBI, 2013) to name a few. Indeed there 
have been many interventions aimed at providing or improving care coordination 
for pediatric patients with asthma and other chronic diseases that have shown 
promising results (Bravata DM et al., 2009; Findley et al., 2011; Loskutova et al., 
2016; Woods et al., 2012).  
 The overarching goals of the GRACE intervention was to optimize the, 
"quality of care and quality of life, decrease excess healthcare use, and prevent 
long-term nursing home placement" (Counsell et al., 2006). The GRACE 
intervention used support teams of a nurse practitioner and clinical social worker 
to partner with low income seniors. The support team would make an initial 
assessment in the patients home which included a medical history, psychosocial 
evaluation, medication review, function assessment, assessment of the patients 
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social support system, and a home evaluation. They would then meet with a 
GRACE interdisciplinary team which included a, "geriatrician, pharmacist, 
physical therapist, mental health social worker, and community-based services 
liaison" to create an individually tailored care plan (Counsell et al., 2006). 
 The GRACE support team would then meet with the patient's PCP to 
present the results from the assessment and discuss and modify the proposed 
plan to align with the patient's healthcare goals. The plan was then implemented. 
Patients receive continued support and case management/coordination from the 
GRACE support team, which in turn was supported with an electronic medical 
record system. This system was also used to longitudinally record and monitor 
outcomes. 
 Over all, the GRACE support team was responsible for helping to create 
and carry out a care plan, at least monthly phone calls to check on patients, 
annual reassessments and follow-up visits, home visits after emergency 
department visits or hospitalizations, coordination between multiple providers and 
sites of care, remaining available to be contacted by their patients via phone, and 
to act as a contact for information or assistance with follow-up care for other 
providers/sites of care (emergency department, specialty care, primary care) 
(Counsell et al., 2006).  
 The creation of the tailored care plan is with respect to GRACE protocols. 
These protocols are specific recommendations to address specific geriatric 
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conditions to target for quality improvement (Counsell et al., 2006; Sloss et al., 
2000). Target conditions were developed by an expert panel based on,  
"(1) prevalence, (2) impact on health and quality of life, (3) 
effectiveness of interventions in improving mortality and quality of 
life, (4) disparity in the quality of care across providers and 
geographic areas, and (5) feasibility of obtaining the data needed to 
test compliance with quality indicators" (Sloss et al., 2000).  
 
The conditions chosen to compose the GRACE protocols are:  
"advance care planning, health maintenance, medication 
management, difficulty walking/falls, chronic pain, urinary 
incontinence, depression, malnutrition/weight loss, visual 
impairment, hearing loss, dementia, and caregiver burden" 
(Counsell et al., 2006). 
 
 Assessment of these conditions were included during the initial and subsequent 
patient assessments. 
 The authors specifically highlight that, the underlying theme of the GRACE 
intervention was to improve coordination and access to care for each patient as a 
whole rather than focusing on individual diseases. In pursuit of this goal, 
implementers sough to,  
"provide patient education, help in improving patient self-
management, and aid in linking the patient with existing health-
system and community-based services. The innovation of GRACE 
is the integration of care across multiple chronic conditions and 
across the continuum of care" (Counsell et al., 2006).  
 
 The GRACE program was evaluated in a randomized control trial by 
Counsell et al (Counsell SR, Callahan CM, Clark DO, & et al, 2007). For 
outcomes measures, researchers used, "The Medical Outcomes 36-Item Short-
Form (SF-36) scales and summary measures; instrumental and basic activities of 
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daily living (ADLs); and ED visits and hospitalizations. Patient health–related 
quality of life was assessed using the 8 SF-36 scales (physical functioning, role-
physical, bodily pain, general health, vitality, social functioning, role-emotional, 
and mental health) (Ware & Sherbourne, 1992) which were aggregated into a 
Physical Component Summary (PCS) and a Mental Component Summary 
(MCS),... Days in bed due to illness or injury over the prior 6 months (more than 
half the day) not counting hospital and nursing home stays were also assessed, 
and Patients' overall satisfaction" (Counsell SR et al., 2007). Evaluations were 
made at baseline and then at every six months for two years by phone call by 
interviewers separate from the intervention process (Counsell SR et al., 2007). 
 The intervention group experienced higher quality of care and process of 
care measures such as more electronic medical record documentation, reception 
of specialty care, and provision of appropriate information or treatment, 
adherence to preventative care, medical care etc (Counsell SR et al., 2007). 
Interestingly, the results from overall comparisons of patient outcomes showed 
differences in only some of the measures after two years. Out of the eight 
measures from the 36 - SF scales, only four showed significant differences 
between treatment and control groups  measured by changes in scores from 
intervention group minus changes in scores from control group. General health 
(2.5 (P= 0.045)), vitality (5.1 (P <0.001)), social functioning (5.3 (P= 0.008), and 
mental health (3.9 (P= 0.001) (Counsell SR et al., 2007). When comparing acute 
care utilizations rates, researchers found similar emergency department visit 
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rates per 1000 patients per year and similar hospitalizations per 1000 patients 
per year for the two years. However when researchers performed a subgroup 
analysis of patients identified as high-risk at baseline, they found significant lower 
rates in the second year for both emergency department visits (848 vs 1314 (P= 
0.03)) and hospitalizations (396 vs 705, P= 0.03)) (See Figure 6) (Counsell SR et 
al., 2007)
  
4
7 
Table 7: GRACE Intervention Components and AHRQ Care Coordination Components. Amended from McDonald 
2007. 
Intervention Description  Component 
Categorization  
Rationale  
GRACE support team acts as catalyst, provides care management, and 
consists of a nurse practitioner and a social worker  
Identify Participants/ 
Specify Roles  
Support team members specified 
and given role of coordinator  
Upon enrollment, the GRACE support team meets with the patient in the 
home to conduct an initial comprehensive geriatric assessment  
Assess Patient  Comprehensive assessment 
anticipates social, medical and other 
needs for coordination  
The support team meets with GRACE interdisciplinary team (including a 
geriatrician, pharmacist, physical therapist, mental health social worker, 
and community-based services liaison) to develop an individualized care 
plan including activation of GRACE care protocols for common geriatric 
conditions  
Identify Participants  Interdisciplinary team members 
identified explicitly  
Develop Care Plan  Standard protocols are tools to 
support coordination with primary 
care physician and other participants  
The GRACE support team meets with the patient's primary care 
physician (PCP) to discuss and modify the plan  
Communicate/ Ensure 
Information Exchange 
Across Care Interfaces  
Primary care-specialty care interface 
addressed with a technique— a 
meeting  
Collaborating with the PCP, the support team implements the plan  Execute Care Plan   
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With support of electronic medical record and longitudinal Web-based 
care management tracking system, the GRACE support team provides 
ongoing care management and coordination of care across geriatric 
syndromes, providers, and care sites  
Monitor and Adjust Care/ 
Monitor and Address 
Coordination Failures  
Electronic medical record (info 
system), a tracking tool (tool) and 
support team (technique) used to 
monitor coordination across 
providers and settings  
The goal of the GRACE model is to optimize health and functional 
status, decrease excess healthcare use, and prevent long-term nursing 
home placement  
Evaluate Health 
Outcomes  
Evaluation built into model, including 
measures to flag coordination issues  
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Figure 6: Acute Care Utilization Rates from Baseline to Year 2, High-risk Subgroup 
Analysis. When comparing emergency department visits per 1000 per year for the two 
years of follow-up, the intervention group  was lower than the control group  (usual care) 
(1445 vs 1748, P= 0.03). Rates were comparable in the first year (823 vs 937, P= 0.22), 
but significantly lower for the intervention group in the second year (643 vs. 841, P= 
0.01) (top left). Hospitalizations rates over both years did not differ significantly between 
intervention and control groups in year one or two (bottom left). When analyzing only 
high-risk patients, emergency department visit rates were did not differ between the 
intervention and control group in the first year, but were significantly lower in the second 
year (848 vs 1314, P= 0.03) (top right). Comparison of hospitalization rates of high risk 
patients also showed similar between intervention and control groups in the first year, 
but significantly lower rates in the second year (396 vs 705, P= 0.03) (bottom right). 
Figure from Counsell 2007.  
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  DISCUSSION AND CONCLUSION  
 In conclusion, asthma care is difficult especially for minority preschoolers 
due to the lack of our current knowledge of the illness' natural history, technical 
limitations in making an accurate diagnosis, as well as social and economical 
factors. The role of race and socioeconomic factors continues to be pervasive 
throughout aspects of life and manifests itself in many forms, one being the 
burden of asthma. In recent decades, there has been uplifting progress to close 
the disparities in care but much work is left to be done.  
 Continued advancements in basic science research and technology will 
help overcome the diagnostic challenges and will hopefully one day provide a 
cure and prevention strategies. However, along with advances in care, further 
quality improvement strategies and intervention studies aimed at closing disparity 
gaps are necessary to improve delivery and access to that care. 
 A review of the literature highlights a number of common obstacles in the 
evaluation of quality improvement programs, in particular complex, multi-level 
campaigns. Using asthma as an example, there are a great number of process 
measures (eg. controller medication prescriptions, asthma action plans 
distributed, patient education) and clinical outcomes (eg. emergency department 
visits, hospitalizations, symptom days, missed days of work/school, etc.) that can 
be recorded. There is some consensus on using emergency visits and 
prescribing controller medications as common measures but the lack of a 
standard indicator makes it difficult to compare studies to each other. Many 
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studies measure some of these outcomes but not others rendering met-analyses 
difficult to conduct or conclude (Okelo et al., 2013). 
 Furthermore, many studies were found to use similar strategies with 
disparate results. The complexity of interventions, environmental and cultural 
contexts, and diversity of healthcare and personal settings, highlight the 
importance of implementation science and context conscious intervention 
planning to ensure accurate strategy evaluation, program fidelity, and the 
translation of proven interventions from a controlled scientific setting to a 
dynamic and messy real world. In other words, when designing an intervention, 
describing the underlying theories of change and recording measures of 
implementation processes are necessary to understand why an intervention does 
or does not work - was success or failure due to the intended approach/strategy 
of the intervention or the implementation of it? Answering this question will help 
direct future research as well as allow for scaling up and adoption of successful 
programs to different settings. 
 The beginning sections of this paper was designed to be a brief overview 
of select aspects of asthma care for children ages zero to five. By focusing on the 
0 to 5 age group, this paper examined the aspects of diagnosis, assessment, and 
medications particular to this group. Due to the scope, no overview of the NAEPP 
guidelines was provided for the components of partnering with/educating patients 
(or in this case caregivers) to facilitate self-management, and the role of 
managing environmental triggers which do not vary across age groups. However, 
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these two areas area also targets for quality improvement strategies and should 
also receive increased attention in future studies.  
 The last section focused only on provider side quality improvement 
interventions. Although many improvements need to be made to increase the 
access, quality, and efficiency of care, interventions that utilized a combination of 
quality improvement strategies or used multi-level approaches - included 
interventions targeting the community and caregiver as well as provider- were 
more often successful than interventions that only included a single strategy 
(Bravata et al., 2007; Findley et al., 2011; To, Cicutto, Degani, McLimont, & 
Beyene, 2008; Woods et al., 2012). All in all, asthma care for preschoolers is 
complex and wrought with barriers that cause an increased morbidity. Continued 
research into comprehensive interventions that combine multiple strategies is 
required to reduce the burden of disease in preschool minorities.
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